Investigation of anti-Müllerian hormone concentrations in relation to natural conception rate and time to pregnancy
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 36 (5) , 568-575
Abstract
No abstract availableKeywords
Funding Information
- European Commission
This publication has 32 references indexed in Scilit:
- Ovarian reserve parameters: a comparison between users and non-users of hormonal contraceptionReproductive BioMedicine Online, 2012
- Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort studyFertility and Sterility, 2012
- Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle‐stimulating hormone starting dose in in vitro fertilisation cyclesBJOG: An International Journal of Obstetrics & Gynaecology, 2012
- Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysisReproductive BioMedicine Online, 2012
- Demographic and medical consequences of the postponement of parenthoodHuman Reproduction Update, 2011
- A Validated Model of Serum Anti-Müllerian Hormone from Conception to MenopausePLOS ONE, 2011
- Antimüllerian Hormone as a Predictor of Natural Fecundability in Women Aged 30–42 YearsObstetrics & Gynecology, 2011
- Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)Human Reproduction Update, 2009
- Undetectable serum anti-Müllerian hormone levels and occurrence of ongoing pregnancyFertility and Sterility, 2008
- Studying Time to Pregnancy by Use of a Retrospective DesignAmerican Journal of Epidemiology, 2005